Sign in
NSRX Stock Price, Chart, Stats & News
Nasus Pharma Ltd.
Save
Nasus Pharma Ltd. (NSRX) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
NSRX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | – |
ROE | – |
D/E | – |
Interest coverage ratio | -37.17x |
NSRX valuation
P/E | – |
P/S | – |
P/B | – |
P/CF | – |
P/FCF | – |
P/OCF | – |
PEG | -0.13x |
EV multiple | -12.50x |
About
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose.
Similar securities
Based on sector and market capitalization
Report issue